Citadel Advisors’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6970 |
|
|
2024
Q2 | – | Sell |
-14,594
| Closed | -$316K | – | 7042 |
|
|
2024
Q1 | $316K | Buy |
14,594
+13,767
| +1,665% | +$298K | ﹤0.01% | 4352 |
|
|
2023
Q4 | $21.3K | Sell |
827
-4,131
| -83% | -$106K | ﹤0.01% | 5364 |
|
|
2023
Q3 | $90.5K | Buy |
4,958
+3,805
| +330% | +$69.5K | ﹤0.01% | 4876 |
|
|
2023
Q2 | $18.1K | Buy |
+1,153
| New | +$18.1K | ﹤0.01% | 5280 |
|
|
2023
Q1 | – | Sell |
-763
| Closed | -$13.4K | – | 6727 |
|
|
2022
Q4 | $13.4K | Buy |
+763
| New | +$13.4K | ﹤0.01% | 5630 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6892 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7120 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 7296 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 7364 |
|
|
2021
Q2 | – | Sell |
-9,571
| Closed | -$264K | – | 7247 |
|
|
2021
Q1 | $264K | Buy |
+9,571
| New | +$264K | ﹤0.01% | 5158 |
|
|
2020
Q3 | – | Sell |
-63,551
| Closed | -$1.48M | – | 5403 |
|
|
2020
Q2 | $1.48M | Buy |
+63,551
| New | +$1.48M | ﹤0.01% | 2504 |
|